Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024
The webcast will also be archived and available for replay at .ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Micro Cap Conference, taking place on November 13-14, 2024.
密歇根州安娜堡/ ACCESSWIRE / 2024年11月8日 / zomedica公司（紐交所美國公司：zom）（「zomedica」或「公司」），一家爲馬匹和伴侶動物提供現場診斷和治療產品的獸醫保健公司，今天宣佈首席執行官拉里·希頓將於2024年11月13-14日在Sidoti微型市值會議上進行演講並與投資者舉行一對一會議。
The presentation will begin at 11:30 ET on November 14, 2024 and can be accessed live here:
演示將於2024年11月14日美東時間11:30開始，並可以在此處實時訪問：
Zomedica will also host virtual one-on-ones with investors on Thursday, November 14, 2024. To register for the presentation or one-on-ones, visit . Registration is free and you don't need to be a Sidoti client.
zomedica還將於2024年11月14日星期四與投資者進行虛擬一對一會議。要註冊演示或一對一會議，請訪問 。註冊免費，您無需成爲Sidoti的客戶。
The webcast will also be archived and available for replay at .
網絡直播也將被存檔，並可在 上重播。
About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi Loop line of therapeutic devices and the TRUFORMA diagnostic platform, the TRUVIEW digital cytology system, and the VetGuardian no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. An NYSE American company, Zomedica grew revenue 33% in 2023 to $25 million and maintains a strong balance sheet with approximately $78 million in liquidity as of September 30, 2024. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as we work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information visit .
關於Zomedica
zomedica是一家領先的馬匹和伴侶動物保健公司，致力於通過爲獸醫提供創新的治療和診斷解決方案來改善動物健康。我們的黃金標準PulseVet衝擊波系統可以加速肌肉骨骼疾病的癒合，已經改變了獸醫治療。我們的產品套件還包括Assisi Loop系列治療設備和TRUFORMA診斷平台，TRUVIEW數字細胞學系統以及VetGuardian非接觸監測系統，所有這些都旨在讓獸醫能夠提供最高水平的護理。總體而言，他們在美國的總可尋址市場超過20億美元。總部位於密歇根州，zomedica在佐治亞州和明尼蘇達州的世界級設施中僱用了約150人並製造和分銷其產品。zomedica是一家紐交所美國公司，2023年營業收入增長了33%，達到2500萬美元，截至2024年9月30日，其流動性約爲7800萬美元。zomedica正在推進其產品系列，利用戰略收購併在國際上擴張，以提高寵物護理的質量，增加寵物家長的滿意度，並改善獸醫診所的工作流程、現金流量和盈利能力。有關更多信息，請訪問。
Follow Zomedica
關注Zomedica
Email Alerts:
LinkedIn:
Facebook:
X (formerly Twitter):
Instagram:
電子郵件提醒：
LinkedIn:
Facebook:
X（以前是Twitter）：
Instagram:
Investor Relations Contact:
Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555
投資者關係聯繫人：
Zomedica投資者關係
investors@zomedica.com
1-734-369-2555
SOURCE: Zomedica Corp.
來源：Zomedica Corp。
譯文內容由第三人軟體翻譯。
